Skip to main content
. 2024 Oct 29;12(11):1231. doi: 10.3390/vaccines12111231

Table 1.

Strategies to reduce the burden of cCMV.

Goal Strategies
Prevent cCMV infection during pregnancy
  • Education to reduce CMV exposures among pregnant persons

  • Vaccination (vaccines in phase I-III clinical trials)

Prevent transmission of cCMV infection to the fetus
  • Test for and detect primary maternal CMV infection during pregnancy

  • Promising findings of high-dose valacyclovir treatment following 1st trimester primary infection (not recommended in the US)

Enhance detection of cCMV infection
  • Newborn screening and early intervention for SNHL

  • Antiviral treatment for symptomatic infants